Tag: drug discovery

Home » drug discovery
Abu Dhabi Health Data Services Partners with Syndesis Health
Post

Abu Dhabi Health Data Services Partners with Syndesis Health

Abu Dhabi Health Data Services (ADHDS), a component of M42’s Digital Health Solutions (DHS) platform, has announced a new collaboration with Syndesis Health. This partnership aims to advance artificial intelligence (AI)-driven genomic analytics and drug discovery. The collaboration is set to leverage Syndesis Health’s expertise in data science and analytics to provide enhanced genomic insights....

Abu Dhabi Health Data Services and Syndesis Health Collaborate to Advance AI-Driven Drug Discovery
Post

Abu Dhabi Health Data Services and Syndesis Health Collaborate to Advance AI-Driven Drug Discovery

Abu Dhabi Health Data Services (ADHDS), which is part of M42’s Digital Health Solutions (DHS) platform, has announced a collaboration with Syndesis Health. This partnership is notable as Syndesis Health is one of the largest holders of phenotype data globally, with over 70 million patient profiles. The term sheet for this collaboration was signed by...